318 related articles for article (PubMed ID: 31351195)
1. Periostin and sclerostin levels in individuals with spinal cord injury and their relationship with bone mass, bone turnover, fracture and osteoporosis status.
Maïmoun L; Ben Bouallègue F; Gelis A; Aouinti S; Mura T; Philibert P; Souberbielle JC; Piketty M; Garnero P; Mariano-Goulart D; Fattal C
Bone; 2019 Oct; 127():612-619. PubMed ID: 31351195
[TBL] [Abstract][Full Text] [Related]
2. Circulating sclerostin is elevated in short-term and reduced in long-term SCI.
Battaglino RA; Sudhakar S; Lazzari AA; Garshick E; Zafonte R; Morse LR
Bone; 2012 Sep; 51(3):600-5. PubMed ID: 22575440
[TBL] [Abstract][Full Text] [Related]
3. Long-term changes in bone metabolism, bone mineral density, quantitative ultrasound parameters, and fracture incidence after spinal cord injury: a cross-sectional observational study in 100 paraplegic men.
Zehnder Y; Lüthi M; Michel D; Knecht H; Perrelet R; Neto I; Kraenzlin M; Zäch G; Lippuner K
Osteoporos Int; 2004 Mar; 15(3):180-9. PubMed ID: 14722626
[TBL] [Abstract][Full Text] [Related]
4. Association between sclerostin and bone density in chronic spinal cord injury.
Morse LR; Sudhakar S; Danilack V; Tun C; Lazzari A; Gagnon DR; Garshick E; Battaglino RA
J Bone Miner Res; 2012 Feb; 27(2):352-9. PubMed ID: 22006831
[TBL] [Abstract][Full Text] [Related]
5. Trabecular bone microarchitecture is deteriorated in men with spinal cord injury.
Modlesky CM; Majumdar S; Narasimhan A; Dudley GA
J Bone Miner Res; 2004 Jan; 19(1):48-55. PubMed ID: 14753736
[TBL] [Abstract][Full Text] [Related]
6. Effect of recent spinal cord injury on wnt signaling antagonists (sclerostin and dkk-1) and their relationship with bone loss. A 12-month prospective study.
Gifre L; Vidal J; Carrasco JL; Filella X; Ruiz-Gaspà S; Muxi A; Portell E; Monegal A; Guañabens N; Peris P
J Bone Miner Res; 2015 Jun; 30(6):1014-21. PubMed ID: 25484108
[TBL] [Abstract][Full Text] [Related]
7. Sclerostin: a candidate biomarker of SCI-induced osteoporosis.
Morse LR; Sudhakar S; Lazzari AA; Tun C; Garshick E; Zafonte R; Battaglino RA
Osteoporos Int; 2013 Mar; 24(3):961-8. PubMed ID: 22801952
[TBL] [Abstract][Full Text] [Related]
8. Associations of serum sclerostin with bone mineral density, markers of bone metabolism and thalassaemia characteristics in adult patients with transfusion-dependent beta-thalassaemia.
Sapunarova K; Goranova-Marinova V; Georgiev P; Deneva T; Tsvetkova S; Grudeva-Popova Z
Ann Med; 2020; 52(3-4):94-108. PubMed ID: 32212941
[No Abstract] [Full Text] [Related]
9. Denosumab increases sublesional bone mass in osteoporotic individuals with recent spinal cord injury.
Gifre L; Vidal J; Carrasco JL; Muxi A; Portell E; Monegal A; Guañabens N; Peris P
Osteoporos Int; 2016 Jan; 27(1):405-10. PubMed ID: 26423406
[TBL] [Abstract][Full Text] [Related]
10. Effect of recent spinal cord injury on the OPG/RANKL system and its relationship with bone loss and the response to denosumab therapy.
Gifre L; Ruiz-Gaspà S; Carrasco JL; Portell E; Vidal J; Muxi A; Monegal A; Guañabens N; Peris P
Osteoporos Int; 2017 Sep; 28(9):2707-2715. PubMed ID: 28580511
[TBL] [Abstract][Full Text] [Related]
11. Effects of Teriparatide and Vibration on Bone Mass and Bone Strength in People with Bone Loss and Spinal Cord Injury: A Randomized, Controlled Trial.
Edwards WB; Simonian N; Haider IT; Anschel AS; Chen D; Gordon KE; Gregory EK; Kim KH; Parachuri R; Troy KL; Schnitzer TJ
J Bone Miner Res; 2018 Oct; 33(10):1729-1740. PubMed ID: 29905973
[TBL] [Abstract][Full Text] [Related]
12. Bone metabolism, bone mineral density and low-energy fractures 10 years after Roux-en-Y gastric bypass.
Blom-Høgestøl IK; Hewitt S; Chahal-Kummen M; Brunborg C; Gulseth HL; Kristinsson JA; Eriksen EF; Mala T
Bone; 2019 Oct; 127():436-445. PubMed ID: 31323430
[TBL] [Abstract][Full Text] [Related]
13. Mendelian Randomization Analysis Reveals a Causal Influence of Circulating Sclerostin Levels on Bone Mineral Density and Fractures.
Zheng J; Maerz W; Gergei I; Kleber M; Drechsler C; Wanner C; Brandenburg V; Reppe S; Gautvik KM; Medina-Gomez C; Shevroja E; Gilly A; Park YC; Dedoussis G; Zeggini E; Lorentzon M; Henning P; Lerner UH; Nilsson KH; Movérare-Skrtic S; Baird D; Elsworth B; Falk L; Groom A; Capellini TD; Grundberg E; Nethander M; Ohlsson C; Davey Smith G; Tobias JH
J Bone Miner Res; 2019 Oct; 34(10):1824-1836. PubMed ID: 31170332
[TBL] [Abstract][Full Text] [Related]
14. Effect of Nutritional Deprivation after Sleeve Gastrectomy on Bone Mass, Periostin, Sclerostin and Semaphorin 4D: A Two-Year Longitudinal Study.
Maïmoun L; Aouinti S; Puech M; Lefebvre P; Deloze M; de Santa Barbara P; Cristol JP; Brabant S; Gautier T; Nedelcu M; Renard E; Picot MC; Mariano-Goulart D; Nocca D
Nutrients; 2023 Oct; 15(20):. PubMed ID: 37892386
[TBL] [Abstract][Full Text] [Related]
15. Whole-body vibration may not affect bone mineral density and bone turnover in persons with chronic spinal cord injury: A preliminary study.
Maïmoun L; Gelis A; Serrand C; Mura T; Brabant S; Garnero P; Mariano-Goulart D; Fattal C
J Spinal Cord Med; 2023 Nov; ():1-13. PubMed ID: 37930641
[TBL] [Abstract][Full Text] [Related]
16. Bone turnover markers as determinants of bone density and fracture in men with distal forearm fractures: the pathogenesis examined in the Mr F study.
Hanusch B; Prediger M; Tuck SP; Walker J; McNally R; Datta HK
Osteoporos Int; 2021 Nov; 32(11):2267-2277. PubMed ID: 33990874
[TBL] [Abstract][Full Text] [Related]
17. Methylation of bone SOST, its mRNA, and serum sclerostin levels correlate strongly with fracture risk in postmenopausal women.
Reppe S; Noer A; Grimholt RM; Halldórsson BV; Medina-Gomez C; Gautvik VT; Olstad OK; Berg JP; Datta H; Estrada K; Hofman A; Uitterlinden AG; Rivadeneira F; Lyle R; Collas P; Gautvik KM
J Bone Miner Res; 2015 Feb; 30(2):249-56. PubMed ID: 25155887
[TBL] [Abstract][Full Text] [Related]
18. Serum Levels of a Cathepsin-K Generated Periostin Fragment Predict Incident Low-Trauma Fractures in Postmenopausal Women Independently of BMD and FRAX.
Bonnet N; Biver E; Chevalley T; Rizzoli R; Garnero P; Ferrari SL
J Bone Miner Res; 2017 Nov; 32(11):2232-2238. PubMed ID: 28766739
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for the development of osteoporosis after spinal cord injury. A 12-month follow-up study.
Gifre L; Vidal J; Carrasco JL; Muxi A; Portell E; Monegal A; Guañabens N; Peris P
Osteoporos Int; 2015 Sep; 26(9):2273-80. PubMed ID: 25939310
[TBL] [Abstract][Full Text] [Related]
20. Bone mass and hormone analysis in patients with spinal cord injury: evidence for a gonadal axis disruption.
Gaspar AP; Brandão CM; Lazaretti-Castro M
J Clin Endocrinol Metab; 2014 Dec; 99(12):4649-55. PubMed ID: 25222754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
